{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:06:18Z","timestamp":1792267578844,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:00:00Z","timestamp":1693699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T00:00:00Z","timestamp":1693699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018778","name":"Al-Azhar University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Naloxone is a non-selective opiate receptor antagonist that is mainly used in the management of acute opioid overdose or intoxication. Previously, naloxone has been shown to have anti-inflammatory and antioxidant properties. Concanavalin A (Con A) model is a common and well established animal model of autoimmune hepatitis that closely resembles the pathological alterations that occur in human. The present study demonstrates that a low dose of naloxone (LD NX) has the ability to improve hepatic function and attenuate hepatic damage induced by Con A as indicated by a clear reduction in serum aminotransferase, bilirubin and enhancement of albumin production as well as liver pathological changes. Also, The proinflammatory cytokines, tumor necrosis factor-\u03b1 (TNF-\u03b1), interferon- \u03b3 (IFN-\u03b3), interleukin-6 (IL-6) and interleukin-1\u03b2 (IL-1\u03b2) were highly suppressed in animals pretreated with LD NX via interference with TLR4\/NF-\u03baB as well as JNK signaling pathways. Furthermore, oxidative stress was highly attenuated in animals pretreated with LD NX as indicated by high reduction in hepatic MDA and an increase in Nrf2, HO-1 expression and subsequent production of the endogenous antioxidants, SOD, CAT and GSH. Collectively, this study demonstrates that LD NX has the ability to mitigate Con A-induced autoimmune hepatitis via modulation of inflammatory cytokines secretion and interference with reactive oxygen species generation.<\/jats:p>","DOI":"10.1007\/s10787-023-01327-5","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T14:01:28Z","timestamp":1693749688000},"page":"2467-2478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4\/NF-\u03baB and Nrf2\/HO-1 signaling pathways"],"prefix":"10.1007","volume":"31","author":[{"given":"Kawther Magdy","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatalla I.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-407X","authenticated-orcid":false,"given":"Amany","family":"Balah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,3]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3109\/13880209.2014.980584","volume":"53","author":"S Akool","year":"2015","unstructured":"Akool S (2015) Molecular mechanisms of the protective role of wheat germ oil against cyclosporin A-induced hepatotoxicity in rats. Pharm Biol 53:1311\u20131317. https:\/\/doi.org\/10.3109\/13880209.2014.980584","journal-title":"Pharm Biol"},{"key":"1327_CR2","doi-asserted-by":"publisher","DOI":"10.24966\/GHR-2566\/100001","author":"M Ballegeer","year":"2016","unstructured":"Ballegeer M, Libert C (2016) Different cell types involved in mediating concanavalin A induced liver injury: a comprehensive overview. J Gastroenterol Hepatol Res. https:\/\/doi.org\/10.24966\/GHR-2566\/100001","journal-title":"J Gastroenterol Hepatol Res"},{"key":"1327_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/13556210410001674130","volume":"9","author":"C Brewer","year":"2004","unstructured":"Brewer C, Wong VS (2004) Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature. Addict Biol 9:81\u201387. https:\/\/doi.org\/10.1080\/13556210410001674130","journal-title":"Addict Biol"},{"key":"1327_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fimmu.2017.00809","volume":"8","author":"R Cant","year":"2017","unstructured":"Cant R, Dalgleish AG, Allen RL (2017) Naltrexone Inhibits IL-6 and TNF\u03b1 production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors. Front Immunol 8:809. https:\/\/doi.org\/10.3389\/fimmu.2017.00809","journal-title":"Front Immunol"},{"key":"1327_CR5","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/biomedicines11061620","volume":"11","author":"P Dara","year":"2023","unstructured":"Dara P, Farooqui Z, Mwale F, Choe C, van Wijnen AJ, Im H-J (2023) Opiate antagonists for chronic pain: a review on the benefits of low-dose naltrexone in arthritis versus non-arthritic diseases. Biomedicines 11:1620. https:\/\/doi.org\/10.3390\/biomedicines11061620","journal-title":"Biomedicines"},{"key":"1327_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cell.2008.11.017","volume":"136","author":"M Das","year":"2009","unstructured":"Das M, Sabio G, Jiang F, Rincon M, Flavell RA, Davis RJ (2009) Induction of hepatitis by JNK-mediated expression of TNF-\u03b1. Cell 136:249\u2013260. https:\/\/doi.org\/10.1016\/j.cell.2008.11.017","journal-title":"Cell"},{"key":"1327_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1136\/gut.2005.076778","volume":"55","author":"MR Ebrahimkhani","year":"2006","unstructured":"Ebrahimkhani MR, Kiani S, Oakley F, Kendall T, Shariftabrizi A, Tavangar SM, Moezi L, Payabvash S, Karoon A, Hoseininik H, Mann DA, Moore KP, Mani AR, Dehpour AR (2006) Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 55:1606\u20131616. https:\/\/doi.org\/10.1136\/gut.2005.076778","journal-title":"Gut"},{"key":"1327_CR8","doi-asserted-by":"publisher","first-page":"114931","DOI":"10.1016\/j.taap.2020.114931","volume":"393","author":"DH El-Kashef","year":"2020","unstructured":"El-Kashef DH, Abdelrahman RS (2020) Montelukast ameliorates concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-\u03b1\/JNK signaling pathway. Toxicol Appl Pharmacol 393:114931. https:\/\/doi.org\/10.1016\/j.taap.2020.114931","journal-title":"Toxicol Appl Pharmacol"},{"key":"1327_CR9","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s10787-022-01058-z","volume":"30","author":"M Elshal","year":"2022","unstructured":"Elshal M, Hazem SH (2022) Escin suppresses immune cell infiltration and selectively modulates Nrf2\/HO-1, TNF-\u03b1\/JNK, and IL-22\/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice. Inflammopharmacology 30:2317\u20132329. https:\/\/doi.org\/10.1007\/s10787-022-01058-z","journal-title":"Inflammopharmacology"},{"key":"1327_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/acel.12322","volume":"14","author":"S Gargiulo","year":"2015","unstructured":"Gargiulo S, Gamba P, Testa G, Rossin D, Biasi F, Poli G, Leonarduzzi G (2015) Relation between TLR4\/NF-\u03baB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability. Aging Cell 14:569\u2013581. https:\/\/doi.org\/10.1111\/acel.12322","journal-title":"Aging Cell"},{"key":"1327_CR11","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1213\/00000539-199403000-00021","volume":"78","author":"PS Glass","year":"1994","unstructured":"Glass PS, Jhaveri RM, Smith LR (1994) Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg 78:536\u2013541. https:\/\/doi.org\/10.1213\/00000539-199403000-00021","journal-title":"Anesth Analg"},{"key":"1327_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clinimag.2020.12.032","volume":"74","author":"NBN Gomes","year":"2021","unstructured":"Gomes NBN, Torres US, Ferraz M, D\u2019Ippolito G (2021) Autoimmune hepatitis in practice, from diagnosis to complications: what is the role of imaging? A clinicoradiological review. Clin Imaging 74:31\u201340. https:\/\/doi.org\/10.1016\/j.clinimag.2020.12.032","journal-title":"Clin Imaging"},{"key":"1327_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/s0196-0644(83)80343-6","volume":"12","author":"KA Handal","year":"1983","unstructured":"Handal KA, Schauben JL, Salamone FR (1983) Naloxone. Ann Emerg Med 12:438\u2013445. https:\/\/doi.org\/10.1016\/s0196-0644(83)80343-6","journal-title":"Ann Emerg Med"},{"key":"1327_CR500","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2015.12.080","volume":"470","author":"R He","year":"2016","unstructured":"He R, Wang L, Zhu J, Fei M, Bao S, Meng Y, Wang Y, Li J, Deng X (2016) Methane-rich saline protects against concanavalin A-induced autoimmune hepatitis in mice through anti-inflammatory and anti-oxidative pathways. Biochem Biophys Res Commun 470:22\u201328. https:\/\/doi.org\/10.1016\/j.bbrc.2015.12.080","journal-title":"Biochem Biophys Res Commun"},{"key":"1327_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","volume":"28","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Maier SF (2008) Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 28:20\u201329. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06321.x","journal-title":"Eur J Neurosci"},{"key":"1327_CR15","doi-asserted-by":"publisher","first-page":"108573","DOI":"10.1016\/j.jnutbio.2020.108573","volume":"89","author":"K Ishida","year":"2021","unstructured":"Ishida K, Kaji K, Sato S, Ogawa H, Takagi H, Takaya H, Yoshiji H (2021) Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS\/TLR4 signaling pathway. J Nutr Biochem 89:108573. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108573","journal-title":"J Nutr Biochem"},{"key":"1327_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bpg.2011.10.006","volume":"25","author":"E Jaeckel","year":"2011","unstructured":"Jaeckel E, Hardtke-Wolenski M, Fischer K (2011) The benefit of animal models for autoimmune hepatitis. Best Pract Res Clin Gastroenterol 25:643\u2013651. https:\/\/doi.org\/10.1016\/j.bpg.2011.10.006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1327_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10787-019-00599-0","volume":"27","author":"W Ji","year":"2019","unstructured":"Ji W, Peng X, Lou T, Wang J, Qiu W (2019) Total favonoids from Tetrastigma hemsleyanum ameliorates infammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg\/Th17 immune homeostasis. Inflammopharmacology 27:1297\u20131307. https:\/\/doi.org\/10.1007\/s10787-019-00599-0","journal-title":"Inflammopharmacology"},{"key":"1327_CR18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/liv.15155","volume":"42","author":"T Katsumi","year":"2022","unstructured":"Katsumi T, Ueno Y (2022) Epidemiology and surveillance of autoimmune hepatitis in Asia. Liver Int 42:2015\u20132022. https:\/\/doi.org\/10.1111\/liv.15155","journal-title":"Liver Int"},{"key":"1327_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10787-016-0305-0","volume":"25","author":"AE Khodir","year":"2017","unstructured":"Khodir AE, Atef H, Said E, ElKashef HA, Salem HA (2017) Implication of Nrf2\/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis. Inflammopharmacology 25:119\u2013135. https:\/\/doi.org\/10.1007\/s10787-016-0305-0","journal-title":"Inflammopharmacology"},{"key":"1327_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1254\/jphs.11160fp","volume":"118","author":"YS Li","year":"2012","unstructured":"Li YS, Wang JX, Jia MM, Liu M, Li XJ, Tang HB (2012) Dragon\u2019s blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats. J Pharmacol Sci 118:43\u201354. https:\/\/doi.org\/10.1254\/jphs.11160fp","journal-title":"J Pharmacol Sci"},{"key":"1327_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.intimp.2018.05.020","volume":"61","author":"Z Li","year":"2018","unstructured":"Li Z, You Y, Griffin N, Feng J, Shan F (2018) Low-dose naltrexone (LDN): a promising treatment in immune-related diseases and cancer therapy. Int Immunopharmacol 61:178\u2013184. https:\/\/doi.org\/10.1016\/j.intimp.2018.05.020","journal-title":"Int Immunopharmacol"},{"key":"1327_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.21037\/atm-21-378","volume":"9","author":"SL Li","year":"2021","unstructured":"Li SL, Cao R, Hu XF, Xiong P, Zhao GY, Xie YN, Yang J (2021) Daidzein ameliorated concanavalin A-induced liver injury through the Akt\/GSK-3\u03b2\/Nrf2 pathway in mice. Ann Transl Med 9:1228. https:\/\/doi.org\/10.21037\/atm-21-378","journal-title":"Ann Transl Med"},{"key":"1327_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2009.09.034","volume":"207","author":"SL Lin","year":"2010","unstructured":"Lin SL, Tsai RY, Tai YH, Cherng CH, Wu CT, Yeh CC, Wong CS (2010) Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords. Behav Brain Res 207:30\u201336. https:\/\/doi.org\/10.1016\/j.bbr.2009.09.034","journal-title":"Behav Brain Res"},{"key":"1327_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.jacc.2006.07.036","volume":"48","author":"SL Liu","year":"2006","unstructured":"Liu SL, Li YH, Shi GY, Chen YH, Huang CW, Hong JS, Wu HL (2006) A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice. J Am Coll Cardiol 48:1871\u20131879. https:\/\/doi.org\/10.1016\/j.jacc.2006.07.036","journal-title":"J Am Coll Cardiol"},{"key":"1327_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbi.2020.08.022","volume":"90","author":"EM Medina-Rodriguez","year":"2020","unstructured":"Medina-Rodriguez EM, Rice KC, Beurel E, Jope RS (2020) (+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors. Brain Behav Immun 90:226\u2013234. https:\/\/doi.org\/10.1016\/j.bbi.2020.08.022","journal-title":"Brain Behav Immun"},{"key":"1327_CR26","doi-asserted-by":"publisher","first-page":"115223","DOI":"10.1016\/j.jep.2022.115223","volume":"292","author":"GA Mohamed","year":"2022","unstructured":"Mohamed GA, Ibrahim SRM, El-Agamy DS, Elsaed WM, Sirwi A, Asfour HZ, Elhady SS (2022) Cucurbitacin E glucoside alleviates concanavalin A-induced hepatitis through enhancing SIRT1\/Nrf2\/HO-1 and inhibiting NF-\u0138B\/NLRP3 signaling pathways. J Ethnopharmacol 292:115223. https:\/\/doi.org\/10.1016\/j.jep.2022.115223","journal-title":"J Ethnopharmacol"},{"key":"1327_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/annrheumdis-2019-216487","volume":"79","author":"E Monnet","year":"2020","unstructured":"Monnet E, Choy EH, McInnes I, Kobakhidze T, de Graaf K, Jacqmin P, Lapeyre G, de Min C (2020) Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Ann Rheum Dis 79:316\u2013323. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216487","journal-title":"Ann Rheum Dis"},{"key":"1327_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-017-1410-3","volume":"390","author":"F Mounieb","year":"2017","unstructured":"Mounieb F, Ramadan L, Akool ES, Balah A (2017) Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species. Naunyn Schmiedebergs Arch Pharmacol 390:1105\u20131115. https:\/\/doi.org\/10.1007\/s00210-017-1410-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1327_CR29","doi-asserted-by":"publisher","first-page":"109573","DOI":"10.1016\/j.intimp.2022.109573","volume":"114","author":"W Que","year":"2023","unstructured":"Que W, Lin H, Li X, Zhang B, Liu M, Hu X, Qiu H (2023) Koumine ameliorates concanavalin A-induced autoimmune hepatitis in mice: involvement of the Nrf2, NF-\u03baB pathways, and gut microbiota. Int Immunopharmacol 114:109573. https:\/\/doi.org\/10.1016\/j.intimp.2022.109573","journal-title":"Int Immunopharmacol"},{"key":"1327_CR30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10787-021-00912-w","volume":"30","author":"H Ruan","year":"2022","unstructured":"Ruan H, Huang Q, Wan B, Yang M (2022) Curcumin alleviates lipopolysaccharides-induced infammation and apoptosis in vascular smooth muscle cells via inhibition of the NF-\u03baB and JNK signaling pathways. Inflammopharmacology 30:517\u2013525. https:\/\/doi.org\/10.1007\/s10787-021-00912-w","journal-title":"Inflammopharmacology"},{"key":"1327_CR31","doi-asserted-by":"publisher","unstructured":"Sahin H, Borkham-Kamphorst E, do O NT, Berres ML, Kaldenbach M, Schmitz P, Maedler K (2013) Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes. Hepatology, 57: 797\u2013805. https:\/\/doi.org\/10.1002\/hep.26069","DOI":"10.1002\/hep.26069"},{"key":"1327_CR32","doi-asserted-by":"publisher","first-page":"108088","DOI":"10.1016\/j.intimp.2021.108088","volume":"100","author":"MH Sharawy","year":"2021","unstructured":"Sharawy MH, El-Kashef DH, Shaaban AA, El-Agamy DS (2021) Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation\/NF-\u03baB inhibition. Int Immunopharmacol. 100:108088. https:\/\/doi.org\/10.1016\/j.intimp.2021.108088","journal-title":"Int Immunopharmacol."},{"key":"1327_CR33","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s10620-009-0732-5","volume":"55","author":"H Shirin","year":"2010","unstructured":"Shirin H, Aeed H, Alin A, Matas Z, Kirchner M, Brazowski E, Bruck R (2010) Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers. Dig Dis Sci 55:268\u2013275. https:\/\/doi.org\/10.1007\/s10620-009-0732-5","journal-title":"Dig Dis Sci"},{"key":"1327_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9437043","author":"E Sucher","year":"2019","unstructured":"Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T (2019) Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies. J Immunol Res. https:\/\/doi.org\/10.1155\/2019\/9437043","journal-title":"J Immunol Res"},{"key":"1327_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2018.10.022","volume":"95","author":"R Taubert","year":"2018","unstructured":"Taubert R, Hupa-Breier KL, Jaeckel E, Manns MP (2018) Novel therapeutic targets in autoimmune hepatitis. J Autoimmun 95:34\u201346. https:\/\/doi.org\/10.1016\/j.jaut.2018.10.022","journal-title":"J Autoimmun"},{"key":"1327_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.2174\/1570159X18666200429001549","volume":"19","author":"D Tewari","year":"2021","unstructured":"Tewari D, Sah AN, Bawari S, Nabavi SF, Dehpour AR, Shirooie S, Braidy N, Fiebich BL, Vacca RA, Nabavi SM (2021) Role of nitric oxide in neurodegeneration: function, regulation, and inhibition. Curr Neuropharmacol 19:114\u2013126. https:\/\/doi.org\/10.2174\/1570159X18666200429001549","journal-title":"Curr Neuropharmacol"},{"key":"1327_CR37","first-page":"1098","volume":"287","author":"G Tiers","year":"1998","unstructured":"Tiers G, K\u00fcsters S, K\u00fcnstle G, Hentze H, Kiemer AK, Wendel A (1998) Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury. J Pharmacol Exp Ther 287:1098\u20131104 (PMID: 9864298)","journal-title":"J Pharmacol Exp Ther"},{"key":"1327_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s0006-8993(97)00509-x","volume":"762","author":"M Tsuruoka","year":"1997","unstructured":"Tsuruoka M, Hiruma Y, Willis WD (1997) The subnucleus reticularis dorsalis is involved in antinociception produced by a low dose of naloxone during carrageenan-induced inflammation. Brain Res 762:264\u2013268. https:\/\/doi.org\/10.1016\/s0006-8993(97)00509-x","journal-title":"Brain Res"},{"key":"1327_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/14740338.6.2.125","volume":"6","author":"E Van Dorp","year":"2007","unstructured":"Van Dorp E, Yassen A, Dahan A (2007) Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf 6:125\u2013132. https:\/\/doi.org\/10.1517\/14740338.6.2.125","journal-title":"Expert Opin Drug Saf"},{"key":"1327_CR41","doi-asserted-by":"publisher","unstructured":"Vergani D, Mieli\u2010Vergani G (2004) Mechanisms of autoimmune hepatitis. Pediatr Transplant. 8: 589\u2013593. doi: https:\/\/doi.org\/10.1111\/j.1399-3046.2004.00288.x","DOI":"10.1111\/j.1399-3046.2004"},{"key":"1327_CR43","doi-asserted-by":"publisher","first-page":"106056","DOI":"10.1016\/j.intimp.2019.106056","volume":"79","author":"N Xu","year":"2020","unstructured":"Xu N, Wang Y, Zhao S, Jiao T, Xue H, Shan F, Zhang N (2020) Naltrexone (NTX) relieves inflammation in the collagen-induced-arthritis (CIA) rat models through regulating TLR4\/NF-\u03baB signaling pathway. Int Immunopharmacol 79:106056. https:\/\/doi.org\/10.1016\/j.intimp.2019.106056","journal-title":"Int Immunopharmacol"},{"key":"1327_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10787-018-0533-6","volume":"27","author":"H Xuan","year":"2019","unstructured":"Xuan H, Yuan W, Chang H, Liu M, Hu F (2019) Anti-infammatory efects of Chinese propolis. in lipopolysaccharide-stimulated human umbilical vein endothelial cells by suppressing autophagy and MAPK\/NF-\u03baB signaling pathway. Inflammopharmacology 27:561\u2013571. https:\/\/doi.org\/10.1007\/s10787-018-0533-6","journal-title":"Inflammopharmacology"},{"key":"1327_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2022.02.030","volume":"182","author":"W Yang","year":"2022","unstructured":"Yang W, Wang Y, Zhang P, Sun X, Chen X, Yu J, Li R (2022) Immune-responsive gene 1 protects against liver injury caused by concanavalin A via the activation Nrf2\/HO-1 pathway and inhibition of ROS activation pathways. Free Radic Biol Med 182:108\u2013118. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.02.030","journal-title":"Free Radic Biol Med"},{"key":"1327_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D (2014) The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol 33:451\u2013459. https:\/\/doi.org\/10.1007\/s10067-014-2517-2","journal-title":"Clin Rheumatol"},{"key":"1327_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jphs.2015.12.006","volume":"130","author":"KF Zhai","year":"2016","unstructured":"Zhai KF, Duan H, Cao WG, Gao GZ, Shan LL, Fang XM, Zhao L (2016) Protective effect of Rabdosia amethystoides (Benth) Hara extract on acute liver injury induced by Concanavalin A in mice through inhibition of TLR4-NF-\u03baB signaling pathway. J Pharmacol Sci 130:94\u2013100. https:\/\/doi.org\/10.1016\/j.jphs.2015.12.006","journal-title":"J Pharmacol Sci"},{"key":"1327_CR48","doi-asserted-by":"publisher","first-page":"e0149754","DOI":"10.1371\/journal.pone.0149754","volume":"11","author":"Y Zhuang","year":"2016","unstructured":"Zhuang Y, Li Y, Li X, Xie Q, Wu M (2016) Atg7 knockdown augments concanavalin A-induced acute hepatitis through an ROS-mediated p38\/MAPK pathway. PLoS One 11:e0149754. https:\/\/doi.org\/10.1371\/journal.pone.0149754","journal-title":"PLoS One"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01327-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01327-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T21:17:17Z","timestamp":1695590237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01327-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,3]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01327-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2873574\/v1","asserted-by":"object"}]},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,3]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest exist, according to the authors, with the publishing of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The institutional animal ethics committee gave its approval to the study\u2019s experimental protocol (Committee reference number: 289).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}